Advertisement

Table of Contents

September 06, 2018; 132 (10)

BLOOD COMMENTARIES

PLENARY PAPER

PERSPECTIVE

BLOOD SPOTLIGHT

CLINICAL TRIALS AND OBSERVATIONS

  • CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET
    David J. Straus, Sin-Ho Jung, Brandelyn Pitcher, Lale Kostakoglu, John C. Grecula, Eric D. Hsi, Heiko Schöder, Leslie L. Popplewell, Julie E. Chang, Craig H. Moskowitz, Nina Wagner-Johnston, John P. Leonard, Jonathan W. Friedberg, Brad S. Kahl, Bruce D. Cheson and Nancy L. Bartlett
  • Nonviral RNA chimeric antigen receptor–modified T cells in patients with Hodgkin lymphoma
    Jakub Svoboda, Susan R. Rheingold, Saar I. Gill, Stephan A. Grupp, Simon F. Lacey, Irina Kulikovskaya, Megan M. Suhoski, J. Joseph Melenhorst, Brandon Loudon, Anthony R. Mato, Sunita Dwivedy Nasta, Daniel J. Landsburg, Matthew R. Youngman, Bruce L. Levine, David L. Porter, Carl H. June and Stephen J. Schuster

HEMATOPOIESIS AND STEM CELLS

LYMPHOID NEOPLASIA

THROMBOSIS AND HEMOSTASIS

BLOOD WORK